Vimarsana
Biggest News Aggregation in the World

Primary Endpoint News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary Endpoint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Endpoint Today - Breaking & Trending Today

Transcripts For CNN Cuomo Prime Time - Vimarsana News

Transcripts For CNN Cuomo Prime Time

peddling denial. but you do get that is not the whole story, right? you understand the vaccine is not a cure-all. it won't get us out of the pandemic, not anytime soon. there are so many out there, i hear you on the radio, i see you on social media, i get your responses to the show. biden's doing a good job, take the win, why do you keep saying the situation is so dire? because it is. vaccine, biden, not enough. he's not trump. he's not going to tell you he's one move away and only he can fix. too many americans insist on falling short. so yeah, the vaccine's a step forward. but we'r...

Largest CIDP Trial Offers Promising Results for Drug Combo - Vimarsana News

Largest CIDP Trial Offers Promising Results for Drug Combo

Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.

Ablative Solutions' TARGET BP I Pivotal Trial Results Demonstrate Significant Reduction in 24-Hour Ambulatory Systolic Blood Pressure Compared to Sham, Using Alcohol-Mediated Renal Denervation - Vimarsana News

Ablative Solutions' TARGET BP I Pivotal Trial Results Demonstrate Significant Reduction in 24-Hour Ambulatory Systolic Blood Pressure Compared to Sham, Using Alcohol-Mediated Renal Denervation

/PRNewswire/ -- Ablative Solutions, Inc., announced that primary trial results from the TARGET BP I Pivotal Trial, evaluating alcohol-mediated renal...

Positive Results for Patients with Non-obstructive Hypertrophic Cardiomyopathy Treated with ... - Vimarsana News

Positive Results for Patients with Non-obstructive Hypertrophic Cardiomyopathy Treated with ...

– Improvements in both patient-reported symptoms of heart failure and ventilatory efficiency during exercise testing were demonstrated –

World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults -April 04, 2024 at 01:54 am EDT - Vimarsana News

World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults -April 04, 2024 at 01:54 am EDT

Antibody persistence of a single-doselive-attenuated chikungunya virus vaccine in adults. World Vaccine Congress, Washington 03-Apr-2024 ...